A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PS / parenteral support

[Related PubMed/MEDLINE]
Total Number of Papers: 26
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PS  (>> Co-occurring Abbreviation)
Long Form:   parenteral support
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure. IBD, QOL, SBS, SBS-QoL
2019 Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24weeks of teduglutide treatment from a randomized controlled study. ---
2019 Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials. non-IBD, SBS-IF
2019 Fragmented management of long-term parenteral support for adult intestinal failure in Finland. IF
2019 Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study. SBS-IF, SOC, TEAEs
2019 Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study. SBS-IF
2019 Survival and CT defined sarcopenia in patients with intestinal failure on home parenteral support. CT-LSMI, IF
2019 Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature. CIF, ESPEN, GOE, SBS
2018 Fasting and Postprandial Plasma Citrulline and the Correlation to Intestinal Function Evaluated by 72-Hour Metabolic Balance Studies in Short Bowel Jejunostomy Patients With Intestinal Failure. HCs, p-citrulline, SBS-IF
10  2018 Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome. SBS-IF
11  2018 Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series. SBS
12  2018 Measurement of Utilities Associated with Parenteral Support Requirement in Patients with Short Bowel Syndrome and Intestinal Failure. HRQoL, SBS, TTO
13  2018 Nutritional Therapy in Adult Short Bowel Syndrome Patients with Chronic Intestinal Failure. IF
14  2018 Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study. PBO, TEAE, TED, TED-TED
15  2017 Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome. ---
16  2017 Single-Center, Adult Chronic Intestinal Failure Cohort Analyzed According to the ESPEN-Endorsed Recommendations, Definitions, and Classifications. ESPEN, IF, SBS
17  2017 Teduglutide: A Review in Short Bowel Syndrome. IF, SBS
18  2017 The use of metabolic balance studies in the objective discrimination between intestinal insufficiency and intestinal failure. BMR, IF, INS, MBSs, ww
19  2016 Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. SBS, TED/TED
20  2015 Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure. AIR, IF, PN, SBS
21  2015 Effect of Teduglutide, a Glucagon-like Peptide 2 Analog, on Citrulline Levels in Patients With Short Bowel Syndrome in Two Phase III Randomized Trials. SBS
22  2015 Teduglutide: a guide to its use in short bowel syndrome. SBS
23  2014 Short bowel syndrome in adults: the need for an interdisciplinary approach and coordinated care. ICCs, IR, SBS
24  2014 Targeted therapy of short-bowel syndrome with teduglutide: the new kid on the block. SBS-IF
25  2013 Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study. GI AE, QOL, SBS
26  2012 Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. ---